Data & Analytics

With a sold-out show, Work Truck Week 2026 is a launchpad for new EVs, hydrogen tech, and smart systems, signaling a robust future for commercial vehicles.

With three new executive appointments, Armada signals an aggressive new strategy under CEO Chris O'Brien to unify its brand and accelerate growth.

Yuki's new 14-day free trial runs its full optimization platform on live Snowflake workloads, promising real savings instead of just simulations.

The acquisition of The Good Crisp Company by a Kroger-backed firm reveals a new playbook where consumer data and health trends dictate the future of snacking.

One of the nation's largest health systems is expanding its use of advanced AI and analytics to redefine clinical excellence and whole-person care.

As Lithuania's grid operator faces a new era of digital demands and renewable integration, a former telecom CTO is set to take the lead in a major strategic shift.

Adimab's stellar 2025 reveals its crucial role as the hidden tech platform driving drug discovery for giants like Lilly and Regeneron.

NYU Langone and tech firm Tempus are launching a new protocol using serial DNA sequencing and AI to create hyper-personalized cancer treatments.

Eason Technology is betting its future on Chinese real estate with a deal that could dilute shareholders by over 80%. But can it get past the NYSE?

A new partnership makes Eli Lilly's powerful AI models available to smaller firms via Revvity's platform, aiming to accelerate innovation with federated learning.

Radiant Ridge Energy's new 40MW project in Alberta bypasses the grid, converting natural gas directly into power for the booming AI and data industry.

With a new CEO from Illumina and Exact Sciences, Quanterix signals a strategic shift from tech development to aggressive market and clinical expansion.

Record AI mega-deals redefine healthcare innovation, yet a broader market contraction creates a new divide for startups and traditional medical sectors.

One Washington Financial and Papilio Collective are launching a new model to embed expert support into fintechs, aiming to close the innovation gap for credit unions.

The investment giant's new podcast season tackles the energy trilemma, exploring AI's power thirst, the return of nuclear, and fossil fuel's role.

With pivotal data for its sickle cell drug and a new myelofibrosis program, Cellarity's AI-driven 'Cell State-Correcting' platform faces a crucial test.

A new partnership brings revolutionary 3D genome mapping from the lab to the clinic, offering new hope for patients with hard-to-treat cancers.

CEO Werner Lanthaler will present FairJourney Bio's data-driven antibody discovery platform at the elite J.P. Morgan conference, signaling major growth.

A newly validated genetic test accurately predicts melanoma risk, offering a non-invasive alternative to the standard surgical biopsy for many patients.

South Korean gim specialist Daingt is leveraging proprietary data and a 20-year legacy to innovate its seaweed, aiming to dominate the booming global market.